AD1K-050 consumable blood kits for Tripler Army Medical Center
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency (DHA) Contracting Activity (DHACA) intends to award a sole source, firm-fixed-price purchase order contract to NANOENTEK AMERICA, INC. for AD1K-050 consumable blood kits. These kits are required for the ADAM-rWBC 1 & 2 machines at the Blood Bank/Laboratory of Tripler Army Medical Center in Hawaii. This is a Notice of Intent, not a request for competitive quotes.
Scope of Work
The requirement is for the supply of AD1K-050 consumable blood kits specifically designed for ADAM-rWBC 1 & 2 machines. NANOENTEK AMERICA, INC. has been identified as the sole manufacturer and distributor of these specialized supply kits and associated equipment. The place of performance is Tripler Army Medical Center, HI 96859.
Contract & Timeline
- Contract Type: Firm-Fixed-Price Purchase Order
- Intended Awardee: NANOENTEK AMERICA, INC. (UEI: WKSAFWSWAZG5, CAGE: 82UB3)
- Period of Performance: Estimated delivery dates span from October 2026 through July 2030, across four option periods.
- Set-Aside: Sole Source (FAR 13.501(a) and FAR 13.106-1(b)(1)(i))
- NAICS Code: 339112 - Surgical and Medical Instrument Manufacturing (Size Standard: 1000 employees)
- PSC Code: 6515 - Medical And Surgical Instruments, Equipment, And Supplies
- Capability Statement Due: March 20, 2026, by 10:00 a.m. Pacific Time
- Published Date: April 14, 2026
Submission & Evaluation
This is not a request for competitive proposals. However, sources interested in challenging the sole source basis must submit a capability statement. This statement should include management, technical data, and cost information, demonstrating the ability to provide the required kits. Capability statements are limited to six (8.5 x 11 inch) pages, using a minimum 10-point font. The Government will consider these submissions to determine if a competitive procurement is feasible, though the decision to compete remains at the Government's sole discretion.
Additional Notes
Capability statements must be emailed as a Microsoft Word or Adobe PDF attachment to Cha-on Gordon at cha-on.p.gordon2.civ@health.mil. No telephone requests or offers will be honored.